Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics

In UK Goodwin Procter, advised on the matter.Goodwin Procter advised Ducentis BioTherapeutics with a team including Graham Defries (Picture – Life Science & Health Care), Robert…

This content is for members only.
Join Now
Already a member? Log in here

Author: Martina Bellini

This content is for members only.
Join Now
Already a member? Log in here